[go: up one dir, main page]

CN107661359A - A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application - Google Patents

A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application Download PDF

Info

Publication number
CN107661359A
CN107661359A CN201711107353.1A CN201711107353A CN107661359A CN 107661359 A CN107661359 A CN 107661359A CN 201711107353 A CN201711107353 A CN 201711107353A CN 107661359 A CN107661359 A CN 107661359A
Authority
CN
China
Prior art keywords
paecilomyces
pupa
base
cordyceps sinensis
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711107353.1A
Other languages
Chinese (zh)
Inventor
韦敏
杨丽
杨清
周珍珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liyang Tianmuhu Development Co ltd
Institute of Botany of CAS
Original Assignee
Liyang Tianmuhu Development Co ltd
Institute of Botany of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liyang Tianmuhu Development Co ltd, Institute of Botany of CAS filed Critical Liyang Tianmuhu Development Co ltd
Priority to CN201711107353.1A priority Critical patent/CN107661359A/en
Publication of CN107661359A publication Critical patent/CN107661359A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明属于中药领域,公开了一种具有增强免疫力抗衰老的组合物及其应用。一种增强免疫力的拟青霉菌蛹基虫草组合物,主要由古尼拟青霉菌蛹基虫草20~70份,细脚拟青霉菌蛹基虫草20~40份和玫烟色拟青霉菌蛹基虫草1~10份组成,优选为由古尼拟青霉菌蛹基虫草50~70份,细脚拟青霉菌蛹基虫草30~40份和玫烟色拟青霉菌蛹基虫草2~5份组成。前述组合物可以进一步制成粉剂、片剂、胶囊或口服液。本发明组合物采用天然原材料制备而成,具有增强免疫力、抗衰老功能。The invention belongs to the field of traditional Chinese medicine and discloses a composition capable of enhancing immunity and anti-aging and an application thereof. An immunity-enhancing Paecilomyces pupae-based Cordyceps composition, which mainly consists of 20-70 parts of Paecilomyces pupae-based Cordyceps pupae, 20-40 parts of Paecilomyces pupae-based Cordyceps pupae and Paecilomyces fumigatus pupae Composed of 1-10 parts of Cordyceps base, preferably 50-70 parts of Paecilomyces pupaeum, 30-40 parts of Paecilomyces pupaeum and 2-5 parts of Paecilomyces pupaeum. composition. The aforementioned composition can be further made into powder, tablet, capsule or oral liquid. The composition of the invention is prepared from natural raw materials and has the functions of enhancing immunity and anti-aging.

Description

一种增强免疫力抗衰老的拟青霉菌蛹基虫草组合物及其应用Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging and its application

技术领域technical field

本发明属于中药领域,涉及一种增强免疫力抗衰老的拟青霉菌蛹基虫草组合物及其应用。The invention belongs to the field of traditional Chinese medicines, and relates to a Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging and an application thereof.

背景技术Background technique

随着时间的推移,所有个体都会发生功能性和器质性衰退的渐进过程,即衰老。衰老又称老化,是生命活动进程中的必经阶段。免疫是指机体接触“抗原性异物”或“异己成分”的一种特异性生理反应。免疫系统对维持机体正常生理功能具有重要意义。当人们营养素摄入不足(蛋白质、维生素、微量元素等缺乏)时会造成机体抵抗力下降,免疫力低下的身体易于被感染或患癌症;免疫力超常也会产生对身体有害的结果,如引发过敏反应、自身免疫疾病等。中青年人在工作和生活的双重压力下,过度消耗与透支体能,免疫力低下,且组织器官提前衰老也趋于年轻化。人们不断寻求可以健康长寿,提高免疫力,战胜各种疾病,提高身体机能的方法,以提高生活质量。因此需要不断开发具有抗衰功能的药食同源的保健品。Aging is a progressive process of functional and organic decline that occurs in all individuals over time. Aging, also known as aging, is an inevitable stage in the process of life activities. Immunity refers to a specific physiological response of the body to contact with "antigenic foreign bodies" or "foreign components". The immune system plays an important role in maintaining normal physiological functions of the body. When people's nutrient intake is insufficient (deficiency of protein, vitamins, trace elements, etc.), the body's resistance will decline, and the body with low immunity is prone to infection or cancer; Allergic reactions, autoimmune diseases, etc. Young and middle-aged people are under the dual pressure of work and life, excessive consumption and overdraft of physical fitness, low immunity, and premature aging of tissues and organs tend to be younger. People are constantly looking for ways to live a long and healthy life, improve immunity, overcome various diseases, and improve physical functions, so as to improve the quality of life. Therefore need to constantly develop the health care products with the same origin of medicine and food with anti-aging function.

冬虫夏草[Cordyceps sinensis(Berk.)Sacc.]是我国医药宝库中与野生人参、鹿茸全称为“三大宝”中的一宝,享有极高的声誉。该药具有益精髓,补虚损、保肺、益肾、止血、化痰等功效,主要用于久咳虚喘、劳嗽咯血、阳痿遗精、腰膝酸痛等症。但由于其生长条件要求高,目前濒于灭绝,被列为国家重点保护野生植物(II级),2016年国家食品药品监督管理局印发通知停止冬虫夏草用于保健食品试点工作(食药监食监三【2016】21号)。冬虫夏草急需寻找合适的替代品。Cordyceps sinensis (Berk.) Sacc.] is one of the "three treasures" in my country's medical treasure house, wild ginseng and velvet antler, and enjoys a very high reputation. The medicine has the functions of benefiting the essence, tonifying deficiency and impairment, protecting the lung, nourishing the kidney, hemostasis, and resolving phlegm. However, due to its high growth conditions, it is currently on the verge of extinction and is listed as a national key protected wild plant (level II). [2016] No. 21). Cordyceps sinensis urgently needs to find a suitable substitute.

拟青霉属Paecilomyces是虫生真菌中的重要类群,已记录约50种,其中许多是害虫的重要自然控制因子,有些是害虫生物防治的重要材料;其中有些种是重要药用真菌资源虫草属 Cordyceps的无性型,有的种如蝉拟青霉P.cicadae(Miquel)Samson还可直接入药。粉拟青霉P. farinosus(Holm ex Gray)Brown、玫烟色拟青霉P.umosoroseus(Wize)Brown&Smith和淡紫拟青霉P.lilacinus(Thom.)Samaon已在前苏联和菲律宾等国注册应用。Paecilomyces is an important group of entomogenous fungi, about 50 species have been recorded, many of which are important natural control factors for pests, and some are important materials for biological control of pests; some of them are important medicinal fungal resources Cordyceps The anamorph of Cordyceps, some species such as Paecilomyces cicadae P.cicadae (Miquel) Samson can also be directly used as medicine. P. farinosus (Holm ex Gray) Brown, P. umosoroseus (Wize) Brown&Smith and P. lilacinus (Thom.) Samaon have been registered in the former Soviet Union and the Philippines application.

拟青霉属真菌的菌丝体及代谢产物具有一定的药用价值,对于这方面的研究主要集中在古尼拟青霉、细脚拟青霉以及蝉拟青霉上,已有研究显示古尼拟青霉具有镇静、镇痛、改善记忆、降低肿瘤活细胞率等药理作用;细脚拟青霉确有增强免疫力、抗癌、增强肺、肾功能、防止动脉硬化、预防贫血、增加小鼠常压耐缺氧、镇痛和镇静和有利于爱滋病恢复等作用;蝉拟青霉能改善脂质物质代谢和保护脏器组织的作用,具有镇静、镇痛、抗辐射、抗惊厥、抗衰老和解热作用,且毒性极小,但对于其他拟青霉菌株研究较少。且目前对拟青霉菌的利用上,除了蛹草拟青霉接种成蛹虫草外,大多均停留在菌丝体的开发利用上。The mycelium and metabolites of Paecilomyces fungi have certain medicinal value. The research in this area mainly focuses on Paecilomyces gourni, Paecilomyces tenipedes and Paecilomyces cicadae. Paecilomyces paecilomyces has pharmacological effects such as sedation, analgesia, memory improvement, and the rate of viable tumor cells; Mice have normal pressure resistance to hypoxia, analgesia and sedation, and are beneficial to the recovery of AIDS; Paecilomyces cicadae can improve lipid metabolism and protect organs and tissues. Anti-aging and antipyretic effects, and minimal toxicity, but less research on other Paecilomyces strains. And in the utilization of Paecilomyces at present, except that Paecilomyces militaris is inoculated into Cordyceps militaris, most of them stay on the development and utilization of mycelium.

为了克服已有开发利用的局限性,需要开发能够从根本上治疗病因并有效地改善疾病症状的新药。In order to overcome the limitations of existing development and utilization, it is necessary to develop new drugs that can fundamentally treat the etiology and effectively improve disease symptoms.

发明内容Contents of the invention

本发明的目的是针对现有技术的缺陷,提供一种增强免疫力抗衰老的拟青霉菌蛹基虫草组合物及其应用。The purpose of the present invention is to provide a Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging and its application.

本发明的另一目的是提供增强免疫力抗衰老的拟青霉菌蛹基虫草组合物及其制备方法。Another object of the present invention is to provide a Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging and a preparation method thereof.

本发明的目的可通过如下技术方案实现:The purpose of the present invention can be achieved through the following technical solutions:

一种增强免疫力抗衰老的拟青霉菌蛹基虫草组合物,主要由古尼拟青霉菌蛹基虫草20~ 70份,细脚拟青霉菌蛹基虫草20~40份和玫烟色拟青霉菌蛹基虫草1~10份组成,优选为由古尼拟青霉菌蛹基虫草50~70份,细脚拟青霉菌蛹基虫草30~40份和玫烟色拟青霉菌蛹基虫草2~5份组成。A Paecilomyces pulitaris-based Cordyceps composition for enhancing immunity and anti-aging, which mainly consists of 20-70 parts of Paecilomyces pupaeci-based Cordyceps, 20-40 parts of Paecilomyces pumilaris-based Cordyceps and rose-smoky Paecilomyces pupae The mold consists of 1 to 10 parts of Cordyceps pupae, preferably 50 to 70 parts of Paecilomyces pupae, 30 to 40 parts of Paecilomyces pupae, and 2 to 2 parts of Paecilomyces pupae. Makes up 5 servings.

所述的增强免疫力抗衰老的拟青霉菌蛹基虫草组合物在制备增强免疫力抗衰老药物中的应用。Application of the Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging in the preparation of anti-aging drugs for enhancing immunity.

一种增强免疫力抗衰老的拟青霉菌蛹基虫草组合物的制备方法,包括如下步骤:A preparation method of a Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging, comprising the following steps:

a.将各组分干燥后粉碎,目数不少于20目;a. Dry and pulverize each component with a mesh size of not less than 20 mesh;

b.将粉碎后的粉状原料按重量百分比称重后均匀得到本发明中药组合物;其中所述的原料的重量百分比组成为:古尼拟青霉菌蛹基虫草20~70份,细脚拟青霉菌蛹基虫草20~40 份和玫烟色拟青霉菌蛹基虫草1~10份组成,优选为由古尼拟青霉菌蛹基虫草50~70份,细脚拟青霉菌蛹基虫草30~40份和玫烟色拟青霉菌蛹基虫草2~5份组成。b. Weigh the pulverized powdery raw materials according to weight percentage to obtain the traditional Chinese medicine composition of the present invention evenly; wherein the weight percentage of the raw materials is composed of: 20-70 parts of Paecilomyces grunnii, Cordyceps militaris, P. Composed of 20-40 parts of Penicillium pupae-based Cordyceps and 1-10 parts of Paecilomyces pupae-based Cordyceps, preferably 50-70 parts of Paecilomyces pupae-based Cordyceps, 30 parts of Paecilomyces pupae-based Cordyceps ~40 parts and 2~5 parts of Paecilomyces fumigatus pupae-based Cordyceps.

c.组合物进一步制成粉剂、片剂、胶囊或口服液。c. The composition is further made into powder, tablet, capsule or oral liquid.

其中,所述古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草、玫烟色拟青霉菌蛹基虫草三种原料粉碎的目数为20-80目。Wherein, the pulverized meshes of the three raw materials of Paecilomyces coronis, Paecilomyces pupae, and Paecilomyces pupae are 20-80 mesh.

按照上述方法制备的增强免疫力抗衰老的拟青霉菌蛹基虫草组合物。The Paecilomyces militaris-based Cordyceps composition for enhancing immunity and anti-aging prepared according to the above method.

所述的增强免疫力抗衰老的拟青霉菌蛹基虫草组合物采用天然原材料制备而成,具有增强免疫力、抗衰老、缓解体力疲劳、辅助改善记忆等功能。本发明活性优于各原料的单一使用,且优于冬虫夏草,为增强免疫力抗衰老药物的开发提供了新方式。The Paecilomyces pulitaris-based Cordyceps composition for enhancing immunity and anti-aging is prepared from natural raw materials, and has functions such as enhancing immunity, anti-aging, relieving physical fatigue, and assisting in improving memory. The activity of the invention is better than that of single use of each raw material, and better than that of Cordyceps sinensis, and provides a new way for the development of immunity-enhancing anti-aging drugs.

具体实施方式Detailed ways

以下将结合具体实施例对本发明做进一步阐述,这些实例仅用于说明目的,而不用于限制本发明范围。本发明的实验动物,购自中国人民解放军军事医学科学院实验动物中心(生产许可证号:SCXK(军)2007-004)。The present invention will be further elaborated below in conjunction with specific examples, and these examples are only for the purpose of illustration, and are not intended to limit the scope of the present invention. The experimental animals of the present invention were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences of the Chinese People's Liberation Army (production license number: SCXK (Army) 2007-004).

实施例1不同拟青霉菌株接种效果的比较The comparison of different Paecilomyces strain inoculation effects of embodiment 1

对7种以鳞翅目为寄主的拟青霉菌株(拟青霉、蛹草拟青霉、古尼拟青霉、环链拟青霉、细脚拟青霉、蝉拟青霉、玫烟色拟青霉)为供试菌株,将所试菌株分别接种于PDA培养基上, 26℃恒温培养14d,用灭菌的打孔器(直径1cm)切取带菌的琼脂片,并将其置于装有玻璃珠的30mL 0.1%吐温-80的无菌水中,振荡30min,待分生孢子完全被打散均匀后,用无菌脱脂纱布过滤,获得孢子悬浮液。用血球计数板测定孢子浓度,并计算出每菌株的产孢量(每菌株设3个重复),最后将孢子悬浮液浓度均稀释为1×107个/mL。Seven kinds of Paecilomyces strains with Lepidoptera as hosts (Paecilomyces, Paecilomyces chrysalis, Paecilomyces gourney, Paecilomyces annulus, Paecilomyces tenipedes, Paecilomyces cicadae, Paecilomyces) was the strain to be tested. Inoculate the tested strains on PDA medium respectively, culture at a constant temperature of 26°C for 14 days, cut out the agar sheet with bacteria with a sterilized puncher (diameter 1 cm), and place it in the 30 mL of 0.1% Tween-80 sterile water with glass beads was shaken for 30 minutes. After the conidia were completely dispersed and uniform, filtered with sterile gauze to obtain a spore suspension. The spore concentration was measured with a hemocytometer, and the spore production of each strain was calculated (three replicates were set for each strain), and finally the concentration of the spore suspension was diluted to 1×10 7 spores/mL.

在超净工作台上采用注射法接种,用1mL注射器给每只蚕蛹注射0.1mL左右菌液,以菌液不溢出为宜,以免体表滋生杂菌、引起交叉感染。注射部位选取翼翅正后方与第3环节交叉点。接种时注射器针头插入蛹体表层1mm左右,然后让针头与蛹体平行,向前推进3mm左右,注入菌液,迅速抽出针头即可,其余接种部位仅需直接插入蛹体表层1mm左右,注入菌液即可。Use the injection method to inoculate on the ultra-clean workbench. Use a 1mL syringe to inject about 0.1mL of the bacterial solution into each silkworm chrysalis. The injection site was selected at the intersection of the rear of the wing and the third link. When inoculating, insert the needle of the syringe into the surface of the pupa about 1mm, then make the needle parallel to the pupa, advance it forward about 3mm, inject the bacterial solution, and quickly pull out the needle. liquid.

接种后移至恒温培养箱中避光、25℃培养约一个月。转色后,通散射光、18-22℃、湿度保持在85%-90%培养至采收。After inoculation, move to a constant temperature incubator to avoid light, and culture at 25°C for about one month. After the color change, it is cultivated by scattered light, kept at 18-22°C and humidity at 85%-90% until harvested.

在接种箱无菌条件下接种,在20-25℃,相对湿度85%-90%下菌丝暗培养时间按照正交试验设计,分别培养2、3、4d。菌丝培养完毕后,进行光照培养,诱导子实体原基产生,1000lx每天光照(9.5-10)h。子实体原基有少量出现时,用0.2mm粗的针扎孔进行通气,每瓶扎5个孔。培养45d后,子实体顶端膨大,即可进行收采。Inoculate under sterile conditions in the inoculation box, and culture the mycelium in dark at 20-25°C and relative humidity of 85%-90%. After the hyphae are cultivated, light culture is carried out to induce the production of fruiting body primordium, and 1000 lx is illuminated (9.5-10) h every day. When a small amount of fruiting body primordia appeared, a 0.2 mm thick needle was used to prick holes for ventilation, and 5 holes were pricked in each bottle. After cultivating for 45 days, the top of the fruiting body expands and can be harvested.

接种后硬化茧数、硬化率、出草率和虫草平均鲜重:硬化率是指蚕蛹接种3-5d后硬化的蚕蛹与接种蚕蛹总数的比值;出草率是指硬化后长出子实体的蚕蛹与硬化蚕蛹总数的比值;虫草平均鲜重是指蚕蛹虫草的总鲜重与出草蚕蛹总数的比值。The number of hardened cocoons after inoculation, the hardening rate, the weed rate and the average fresh weight of Cordyceps: the hardening rate refers to the ratio of the hardened silkworm chrysalis after silkworm chrysalis inoculation 3-5 days to the total number of inoculated silkworm chrysalis; The ratio of the total number of hardened silkworm chrysalis; the average fresh weight of Cordyceps refers to the ratio of the total fresh weight of silkworm chrysalis Cordyceps to the total number of silkworm chrysalis.

表1不同菌株接种蚕蛹接种效果比较研究Table 1 Comparative study on inoculation effect of silkworm chrysalis inoculated with different strains

表1数据也可以看出拟青霉菌株,其硬化率较低,出草后的子实体品质低。蛹草拟青霉、玫烟色拟青霉两个菌种,其接种后的硬化率分别达到98%和99.3%;出草率分别达到96.7%和 98.6%,子实体品质也较高。除了拟青霉菌株,其余六种拟青霉菌在硬化率、出草率和虫草平均鲜重三个指标方面无显著性差异。It can also be seen from the data in Table 1 that the Paecilomyces strain has a low hardening rate, and the quality of the fruiting body after the grass is low. Paecilomyces chrysalis and Paecilomyces fumigatus had hardening rates of 98% and 99.3% respectively after inoculation; the rate of weeding reached 96.7% and 98.6% respectively, and the fruiting body quality was also high. Except for Paecilomyces strains, the other six Paecilomyces strains had no significant difference in the three indicators of hardening rate, weeding rate and average fresh weight of Cordyceps.

实施例2不同蚕蛹-拟青霉菌株子实体对血虚小鼠免疫活力的影响比较研究Example 2 Comparative study on the effect of fruiting bodies of different silkworm chrysalis-Paecilomyces strains on the immune activity of blood-deficiency mice

动物分组及处理:取ICR小鼠,随机分为正常组,模型组,阳性对照(香菇多糖组),接种后子实体(拟青霉、蛹草拟青霉、古尼拟青霉、环链拟青霉、细脚拟青霉、蝉拟青霉、玫烟色拟青霉)单剂量组,共10组,每组20只。试验组小鼠按剂量分别灌胃给药(0.4ml),正常组与模型组小鼠同时灌服等容量生理盐水,阳性对照组灌服香菇多糖水溶液0.4ml,每日1次,连续15天。从第12天起模型组与给药组小鼠腹腔注射环磷酰胺80mg·kg-1,连续3天,正常组小鼠同时注射等体积生理盐水。Grouping and treatment of animals: ICR mice were randomly divided into normal group, model group, positive control (lentinan group), fruiting bodies after inoculation (Paecilomyces, Paecilomyces pupaecillum, Paecilomyces coronis, Paecilomyces annulus) Penicillium, Paecilomyces tenipedes, Paecilomyces cicadae, Paecilomyces fumigatus) single-dose groups, a total of 10 groups, 20 rats in each group. The mice in the test group were given intragastric administration (0.4ml) according to the dose, the mice in the normal group and the model group were given equal volume of normal saline at the same time, and the positive control group was given 0.4ml of lentinan aqueous solution, once a day, for 15 consecutive days . From the 12th day, the mice in the model group and the treatment group were intraperitoneally injected with cyclophosphamide 80 mg·kg -1 for 3 consecutive days, and the mice in the normal group were injected with an equal volume of normal saline at the same time.

指标的检测:各组于第15天末次给药1.0小时后,每组10只尾静脉注射用生理盐水稀释5倍的印度墨汁10ml/kg体质量,立即计时。于注射后2min(t1),12min(t2)分别从内眦静脉丛取血20μl,加到2ml 0.1%Na2CO3溶液中摇匀,以Na2CO3溶液作空白对照,用分光光度计在600nm波长处测吸光度值(A)。第2次采血结束后,立即处死小鼠,称体重;取胸腺、肝脏和脾脏,用滤纸吸干脏器表面血污后称其湿重,计算脾指数和胸腺指数。脾指数(mg /g)=脾重量(mg)/体重(g);胸腺指数(mg/g)=胸腺重量(mg)/体重(g)。另10只小鼠行摘眼球取血,测外周血象。计算吞噬指数,按下列公式计算廓清指数K和校正廓清指数α。Detection of indicators: 1.0 hours after the last administration on the 15th day, 10 rats in each group were injected with 10ml/kg body weight of Indian ink diluted 5 times with normal saline into the tail vein, and the time was immediately measured. At 2min (t1) and 12min (t2) after the injection, 20μl of blood was collected from the inner canthal venous plexus, added to 2ml of 0.1% Na 2 CO 3 solution and shaken evenly. The Na 2 CO 3 solution was used as the blank control, and a spectrophotometer was used to Measure the absorbance value (A) at a wavelength of 600nm. Immediately after the second blood collection, the mice were killed, and their body weight was weighed; the thymus, liver and spleen were taken out, and the blood stains on the surface of the organs were blotted with filter paper, and the wet weight was measured to calculate the spleen index and thymus index. Spleen index (mg/g)=spleen weight (mg)/body weight (g); thymus index (mg/g)=thymus weight (mg)/body weight (g). The other 10 mice were removed from the eyeballs to obtain blood, and the peripheral blood was measured. Calculate the phagocytosis index, calculate the clearance index K and corrected clearance index α according to the following formula.

K=(lgA1-lgA2)/(t2-t1);α=K1/3×体重/(肝脏重量+脾脏重量)。K=(lgA1-lgA2)/(t2-t1); α=K 1/3 ×body weight/(liver weight+spleen weight).

其中A为血样吸收度值,t1,t2为注射墨汁后采血时间。Where A is the absorbance value of the blood sample, and t1 and t2 are the blood collection time after ink injection.

从表2可看出,模型组小鼠白细胞(WBC)、血小板(PLT)和血红蛋白(Hb)与较正常组相比均有显著下降(p<0.01),红细胞(RBC)明显下降,提示环磷酰胺造血虚模型成功。与模型组比较,蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草组小鼠的白细胞、血小板和血红蛋白的量均有显著升高(p<0.01),红细胞数明显回升,趋于正常,说明蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草均能有效改善血虚小鼠的外周血象,且对外周血象的作用相当。其余蚕蛹-拟青霉菌株子实体组小鼠的白细胞、血小板和血红蛋白的量与模型组无显著性差异(p>0.05)。As can be seen from Table 2, compared with the normal group, white blood cells (WBC), platelets (PLT) and hemoglobin (Hb) in the model group were significantly decreased (p<0.01), and red blood cells (RBC) were significantly decreased, suggesting that the ring Phosphoramide hematopoietic deficiency model was successful. Compared with the model group, the leukocytes, platelets and hemoglobin levels of mice in the Paecilomyces pumilaris, Paecilomyces pumilaris, Paecilomyces pupaeci, and Paecilomyces pumilaris groups The amount of red blood cells all increased significantly (p<0.01), and the number of red blood cells rebounded significantly, tending to normal, indicating that Paecilomyces pumilaris, Paecilomyces pupae, Cordyceps pupae, Paecilomyces pupae Both Paecilomyces chrysogenum and Cordyceps pupae can effectively improve the peripheral blood of mice with blood deficiency, and the effect on peripheral blood is equivalent. The amount of white blood cells, platelets and hemoglobin in the other silkworm chrysalis-Paecilomyces strain fruiting body groups had no significant difference from the model group (p>0.05).

表2不同蚕蛹-拟青霉菌株子实体对血虚小鼠外周血象的影响比较(n=20)Table 2 Comparison of the effect of fruiting bodies of different silkworm chrysalis-Paecilomyces strains on the peripheral blood of mice with blood deficiency ( n=20)

注:与模型组比较,*:p<0.05,**:p<0.01Note: Compared with the model group, *: p<0.05, **: p<0.01

从表3看出:模型组小鼠的免疫脏器指数与正常组相比均有显著下降(p<0.01),与模型组比较,蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草组小鼠的免疫脏器指数均显著升高(p<0.01);模型组小鼠的K值和α值与正常组相比均显著降低(p<0.01),与模型组比较,蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草组小鼠的K值和α值均显著增加(p<0.01, p<0.05)。总体来说,蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草对血虚小鼠免疫脏器指数和单核巨噬细胞吞噬功能的影响相当。其余蚕蛹-拟青霉菌株子实体组小鼠的K值和α值与模型组无显著性差异(p>0.05)。It can be seen from Table 3 that the immune organ index of the mice in the model group was significantly lower than that of the normal group (p<0.01). The immune organ indexes of the mice in the Cordyceps, Paecilomyces finelegs, and Paecilomyces pumilaris groups were significantly increased (p<0.01); Compared with the model group, Paecilomyces militaris, Paecilomyces pupae, Cordyceps pupaecilium, Paecilomyces pupae The K value and α value of the mice in the Cordyceps-based group were significantly increased (p<0.01, p<0.05). In general, Paecilomyces pumilaris, Paecilomyces pulitaris, Paecilomyces pumilaris, and Paecilomyces pumilaris had different effects on the immune organ index and single The effect on phagocytosis of nuclear macrophages was comparable. The K value and α value of the other silkworm chrysalis-Paecilomyces strain fruiting body groups had no significant difference from the model group (p>0.05).

表3不同蚕蛹-拟青霉菌株子实体对血虚小鼠免疫脏器指数和单核巨噬细胞吞噬功能的影响(n=20)Table 3 Effects of fruiting bodies of different silkworm chrysalis-Paecilomyces strains on the immune organ index and phagocytic function of mononuclear macrophages in mice with anemia deficiency ( n=20)

注:与模型组比较,*:p<0.05,**:p<0.01Note: Compared with the model group, *: p<0.05, **: p<0.01

结果显示蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草能够治疗血虚小鼠的免疫功能障碍,其作用无显著性差异,说明蛹草拟青霉、古尼拟青霉、细脚拟青霉菌和玫烟色拟青霉菌感染蚕蛹后可以产生具有免疫抑制活力的子实体,为开发新型药用拟青霉菌株研究提供参考。The results showed that Paecilomyces militaris Cordyceps militaris, Paecilomyces militaris Cordyceps militaris, Paecilomyces tenipedum and Paecilomyces pupaeci can treat the immune dysfunction of mice with blood deficiency. There was no significant difference, indicating that Paecilomyces pupaecillum, Paecilomyces gourni, Paecilomyces tenipedes and Paecilomyces fumigatus infected silkworm chrysalis can produce fruiting bodies with immunosuppressive activity. Strain research provides a reference.

实施例3免疫抑制活性蛹拟青霉组合物的制备The preparation of embodiment 3 immunosuppressive active Paecilomyces pulitaris composition

将蛹草拟青霉蛹基虫草、古尼拟青霉菌蛹基虫草、细脚拟青霉菌蛹基虫草和玫烟色拟青霉菌蛹基虫草干燥后粉碎,目数不少于20目;Dry and pulverize Paecilomyces pupae, Paecilomyces pupae, Paecilomyces pupae, and Paecilomyces pulverus, with a mesh size of not less than 20 meshes;

样品1:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:古尼拟青霉菌蛹基虫草50份,细脚拟青霉菌蛹基虫草40份和玫烟色拟青霉菌蛹基虫草10份组成;Sample 1: The pulverized powdery raw materials were weighed by weight percentage to obtain a traditional Chinese medicine composition evenly; wherein the weight percentage of the raw materials consisted of: 50 parts of Paecilomyces grunnii pupae, 50 parts of Paecilomyces tenipedes pupae Composed of 40 parts of Cordyceps base and 10 parts of Paecilomyces pupaeci;

样品2:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:古尼拟青霉菌蛹基虫草70份,细脚拟青霉菌蛹基虫草20份和玫烟色拟青霉菌蛹基虫草10份组成;Sample 2: The pulverized powdery raw materials were weighed by weight percentage to obtain a traditional Chinese medicine composition evenly; wherein the weight percentage of the raw materials consisted of: 70 parts of Paecilomyces grunidus pupae, 70 parts of Paecilomyces tenipedes pupae Composed of 20 parts of Cordyceps genus and 10 parts of Paecilomyces fumigatus pupae;

样品3:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:古尼拟青霉菌蛹基虫草58份,细脚拟青霉菌蛹基虫草40份和玫烟色拟青霉菌蛹基虫草2份组成;Sample 3: The pulverized powdery raw materials were weighed by weight percentage to obtain a traditional Chinese medicine composition evenly; wherein the weight percentage of the raw materials consisted of: 58 parts of Paecilomyces grunidus pupae, 58 parts of Paecilomyces tenipedes pupae Composed of 40 parts of Cordyceps base and 2 parts of Paecilomyces pupaeci;

样品4:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:蛹草拟青霉蛹基虫草100份;Sample 4: The pulverized powdery raw materials were weighed by weight percentage to obtain a traditional Chinese medicine composition uniformly; wherein the weight percentage of the raw materials was composed of: 100 parts of Paecilomyces pumilaris pupae;

样品5:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:古尼拟青霉菌蛹基虫草100份;Sample 5: The pulverized powdery raw material was weighed according to the weight percentage to obtain a traditional Chinese medicine composition; wherein the weight percentage of the raw material was composed of: 100 parts of Paecilomyces gunini Cordyceps militaris;

样品6:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:细脚拟青霉菌蛹基虫草100份;Sample 6: The pulverized powdery raw material was weighed according to the weight percentage to obtain a traditional Chinese medicine composition; wherein the weight percentage of the raw material was composed of: 100 parts of Paecilomyces tenipedes Cordyceps militaris;

样品7:将粉碎后的粉状原料按重量百分比称重后均匀得到中药组合物;其中所述的原料的重量百分比组成为:玫烟色拟青霉菌蛹基虫草100份;Sample 7: The pulverized powdery raw material was weighed by weight percentage to obtain a traditional Chinese medicine composition uniformly; wherein the weight percentage of the raw material was composed of: 100 parts of Paecilomyces fumigatus Cordyceps militaris;

实施例4免疫抑制活性蛹拟青霉组合物活性确立Example 4 Immunosuppressive Activity Paecilomyces pulitaris Composition Active Establishment

参照卫生部《保健食品检验与评价技术规范》(2003年版)中的方法对实施例3制备的样品1-7进行小鼠免疫功能的测定。With reference to the method in the Ministry of Health "Technical Specifications for Inspection and Evaluation of Health Food" (2003 edition), samples 1-7 prepared in Example 3 were used to measure the immune function of mice.

ConA诱导小鼠脾淋巴细胞转化试验(MTT法)ConA-induced mouse spleen lymphocyte transformation assay (MTT method)

各组灌胃给样品,每天1次,连续30d。在试验第30天,每鼠无菌取脾,置于盛有适量无菌Hank's液的小平皿中,用镊子轻轻撕碎,制成单细胞悬液,200目筛网过滤,洗涤,计数,最后用RPMI1640完全培养液调整细胞浓度为3×106个·mL-1。将细胞悬液分两孔加入24孔培养板中,每孔1mL,1孔加75μL ConA液(相当于7.5μg·mL-1),另1孔作为对照,置 37℃、5%CO 2培养箱中培养72h。培养结束前4h,每孔轻轻吸去上清液0.7mL,加入0.7mL 不含小牛血清的RPMI1640培养液,同时加入MTT(5mg·mL-1)50μL·孔-1,继续培养4h。培养结束后,每孔加入1mL酸性异丙醇,吹打混匀,使紫色结晶完全溶解。在570nm波长处测定光密度值(OD)。最后用加ConA孔的光密度值减去不加ConA孔的光密度值代表淋巴细胞的增殖能力。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 30th day of the experiment, aseptically remove the spleen from each mouse, put it in a small plate filled with an appropriate amount of sterile Hank's solution, and gently tear it up with tweezers to make a single-cell suspension, filter through a 200-mesh sieve, wash, and count , and finally adjust the cell concentration to 3×10 6 ·mL -1 with RPMI1640 complete culture medium. Add the cell suspension into two wells of a 24-well culture plate, 1 mL per well, add 75 μL of ConA solution (equivalent to 7.5 μg·mL -1 ) to 1 well, and use the other well as a control, culture at 37°C, 5% CO 2 Cultivate in the box for 72h. 4 hours before the end of the culture, 0.7 mL of the supernatant was gently aspirated from each well, and 0.7 mL of RPMI1640 culture solution without calf serum was added. At the same time, 50 μL·well of MTT (5 mg·mL -1 ) was added, and the culture was continued for 4 hours. After culturing, add 1mL of acidic isopropanol to each well, and mix well by pipetting to completely dissolve the purple crystals. Optical density (OD) was measured at a wavelength of 570 nm. Finally, subtract the optical density value of the well without ConA from the optical density value of the well with ConA to represent the proliferation ability of lymphocytes.

表4不同样品对ConA诱导的小鼠脾淋巴细胞增殖能力及绵羊红细胞诱导小鼠迟发型变态反应(DTH)的影响(x±s,n=10)Table 4 Effects of different samples on ConA -induced proliferation of mouse spleen lymphocytes and sheep erythrocytes induced delayed-type hypersensitivity (DTH) in mice ( x±s , n=10)

由表4中脾淋巴细胞ConA刺激后的净增值(以OD570值表示)数据可见,与阴性对照组比较,样品1-7组均能提高ConA诱导的小鼠脾淋巴细胞的增殖能力。样品1-3活性优于样品4-7,与阴性对照组有显著性差异(p<0.05),可见组合物(样品1-3)活性优于单一子实体,具有刺激脾淋巴细胞增值作用。It can be seen from the data of the net proliferation value (expressed in OD570 value) of splenic lymphocytes stimulated by ConA in Table 4 that compared with the negative control group, samples 1-7 groups can all increase the proliferation ability of ConA-induced mouse splenic lymphocytes. The activity of samples 1-3 is better than that of samples 4-7, which is significantly different from the negative control group (p<0.05). It can be seen that the activity of the composition (sample 1-3) is better than that of a single fruiting body, and has the effect of stimulating spleen lymphocyte proliferation.

绵羊红细胞(SRBC)诱导小鼠迟发型变态反应(DTH)试验(足跖增厚法)Delayed type hypersensitivity (DTH) test in mice induced by sheep erythrocytes (SRBC) (foot plantar thickening method)

各组灌胃给样品,每天1次,连续30d。在试验第25天,每只鼠腹腔注射0.2mL 2%(v·v-1) 压积绵羊红细胞(SRBC)悬液,进行免疫。免疫后4d,测量左后足跖部厚度,然后在测量部位皮下注射20%(v·v-1)SRBC,每只鼠20μL(约1×108个SRBC),注射后于24h测量左后足跖部厚度,同一部位测量3次,取平均值。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 25th day of the experiment, each mouse was injected intraperitoneally with 0.2 mL of 2% (v·v -1 ) packed sheep red blood cell (SRBC) suspension for immunization. 4 days after immunization, measure the thickness of the plantar part of the left hind foot, then inject 20% (v·v -1 ) SRBC subcutaneously at the measurement site, 20 μL per mouse (about 1×10 8 SRBCs), and measure the left hind foot 24 hours after injection The thickness of the sole of the foot was measured 3 times at the same site, and the average value was taken.

由表4可知,绵羊红细胞(SRBC)诱导小鼠DTH(足跖增厚法)试验表明,样品1-7组能提高小鼠左后足跖部厚度差24h与0h厚度差值,差异有显著性(p<0.05),表明样品1-7能提高绵羊红细胞(SRBC)诱导小鼠足跖部肿胀程度,具有促进迟发型变态反应的作用。由此可见,样品1-7可增强小鼠细胞免疫功能。As can be seen from Table 4, the sheep red blood cell (SRBC) induced mouse DTH (plantar thickening method) test showed that the samples 1-7 groups can improve the difference between the thickness difference of the left hind foot plantar part of the mouse at 24h and the thickness difference at 0h, and the difference is significant. (p<0.05), indicating that samples 1-7 can increase the degree of swelling of the soles of the mice induced by sheep red blood cells (SRBC), and have the effect of promoting delayed hypersensitivity. It can be seen that samples 1-7 can enhance the cellular immune function of mice.

小鼠血清溶血素测定(血凝法)Determination of mouse serum hemolysin (hemagglutination method)

各组灌胃给样品,每天1次,连续30d。在试验第25天,每只鼠腹腔注射0.2mL 2%(v·v-1) 压积绵羊红细胞(SRBC)悬液,进行免疫。5d后,取血离心,收集血清,用生理盐水将血清倍比稀释,37℃温箱孵育3h,观察血球凝集程度,计算抗体积数。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 25th day of the experiment, each mouse was injected intraperitoneally with 0.2 mL of 2% (v·v -1 ) packed sheep red blood cell (SRBC) suspension for immunization. After 5 days, the blood was taken and centrifuged, and the serum was collected. The serum was serially diluted with normal saline, incubated in a 37°C incubator for 3 hours, the degree of hemagglutination was observed, and the anti-volume was calculated.

抗体生成细胞检测(Jerne改良玻片法)Antibody producing cell detection (Jerne modified slide method)

各组灌胃给样品,每天1次,连续30d。在试验第25天,每只鼠腹腔注射0.2mL 2%(v·v-1) 压积绵羊红细胞(SRBC)悬液,进行免疫。5d后,每鼠无菌取脾,置于盛有适量无菌Hank's 液的小平皿中,用镊子轻轻撕碎,制成单细胞悬液,200目筛网过滤,洗涤,计数,最后用 RPMI1640完全培养液调整细胞浓度为5×106个·mL-1。将表层培养基(1g琼脂糖加双蒸水至 100mL)加热溶解后,放45℃水浴保温,与等量pH7的Hank's液混合,分装小试管,每管0.5mL,再向管内加50μL10%SRBC(v·v-1,用SA液配制),20μL脾细胞悬液(5×106个·mL-1),迅速混匀,倾倒于已刷琼脂糖薄层的玻片上,做平行片,待琼脂凝固后,将玻片水平扣放在片架上,放入二氧化碳培养箱中温育1-1.5h,然后用SA缓冲液稀释的补体(1∶8)加入到玻片架凹槽内,继续温育1-1.5h后,计数溶血空斑数。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 25th day of the experiment, each mouse was injected intraperitoneally with 0.2 mL of 2% (v·v- 1 ) packed sheep red blood cell (SRBC) suspension for immunization. After 5 days, the spleen was aseptically taken from each mouse, placed in a small plate containing an appropriate amount of sterile Hank's solution, and gently torn up with tweezers to make a single-cell suspension, filtered through a 200-mesh screen, washed, counted, and finally used RPMI1640 complete culture medium was used to adjust the cell concentration to 5×10 6 ·mL -1 . Heat and dissolve the surface medium (1g agarose plus double distilled water to 100mL), put it in a water bath at 45°C to keep warm, mix it with an equal amount of Hank's solution of pH7, divide into small test tubes, 0.5mL per tube, and then add 50μL of 10% SRBC (v·v -1 , prepared with SA solution), 20 μL splenocyte suspension (5×10 6 ·mL -1 ), mix quickly, pour on a glass slide brushed with agarose thin layer, and make parallel slices After the agar is solidified, place the slide horizontally on the slide rack, put it in a carbon dioxide incubator and incubate for 1-1.5h, then add complement (1:8) diluted with SA buffer into the groove of the slide rack , after continuing to incubate for 1-1.5h, count the number of hemolytic plaques.

表5不同样品对小鼠抗体生成细胞及血清溶血素的影响(n=10)Table 5 Effects of different samples on mouse antibody producing cells and serum hemolysin ( n=10)

由表5可知,样品1-7组小鼠的血清溶血素抗体积数值和阴性对照组相比较,差异均无显著性(p>0.05)。与阴性对照组比较,样品1-7组均能提高小鼠溶血空斑数,差异均有显著性(p <0.05),其中样品1-3组有极显著性(p<0.01)。表明样品1-7具有促进抗体生成细胞增值的作用,从而有助于增强小鼠体液免疫功能。It can be seen from Table 5 that there is no significant difference between the serum hemolysin anti-volume values of the mice in sample 1-7 groups and the negative control group (p>0.05). Compared with the negative control group, the sample 1-7 groups can increase the number of hemolytic plaques in the mice, and the difference is significant (p <0.05), and the sample 1-3 group is extremely significant (p <0.01). It shows that samples 1-7 have the effect of promoting the proliferation of antibody-producing cells, thereby helping to enhance the humoral immune function of mice.

小鼠腹腔巨噬细胞吞噬鸡红细胞试验(半体内法)Phagocytosis of chicken red blood cells by mouse peritoneal macrophages (semi-in vivo method)

各组灌胃给样品,每天1次,连续30d。动物处死前30min,每鼠腹腔内注射20%(v·v-1) 鸡红细胞悬液1mL,处死后再注入2mL生理盐水,取腹腔液滴片,38℃温箱孵育30min,固定,染色,镜检,计数100个巨噬细胞,计算吞噬率及吞噬指数。The samples were given to each group by gavage, once a day, for 30 consecutive days. 30 minutes before the animals were sacrificed, each mouse was intraperitoneally injected with 1 mL of 20% (v·v -1 ) chicken erythrocyte suspension, and then injected with 2 mL of normal saline, and the peritoneal fluid drops were taken, incubated in a 38°C incubator for 30 minutes, fixed, and stained. Microscopic examination, 100 macrophages were counted, and the phagocytosis rate and phagocytosis index were calculated.

表6不同样品对小鼠腹腔巨噬细胞吞噬鸡红细胞及碳廓清试验吞噬指数的影响( n=10)Table 6 Effects of different samples on mouse peritoneal macrophages phagocytosis of chicken red blood cells and carbon clearance test phagocytosis index ( n = 10)

由表6可知,样品1-7组小鼠腹腔巨噬细胞吞噬鸡红细胞的吞噬率、吞噬指数和阴性对照组比较,差异无显著性(p>0.05)。样品1-7组小鼠碳廓清能力和阴性对照组比较,差异无显著性(p>0.05)。It can be seen from Table 6 that the phagocytosis rate and phagocytosis index of mouse peritoneal macrophages phagocytizing chicken erythrocytes in sample 1-7 groups were not significantly different from those of the negative control group (p>0.05). Compared with the negative control group, there was no significant difference between the carbon clearance ability of the mice in the sample 1-7 group (p>0.05).

小鼠碳廓清试验法mouse carbon clearance test

各组灌胃给样品,每天1次,连续30d。在试验第30天,每鼠尾静脉注入印度墨汁,按每10g体重0.1mL计算,待墨汁注入,立即计时。注入墨汁后2min、10min分别从内眦静脉丛取血20μL,并将其加到2mL0.1%Na2CO3溶液中,用721分光光度计在600nm波长处测光密度值(OD),以Na2CO3溶液作空白对照。第2次采血结束后,立即处死小鼠,取肝脏和脾脏,用滤纸吸干脏器表面血污,称重。计算吞噬指数。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 30th day of the experiment, Indian ink was injected into the tail vein of each mouse, calculated as 0.1 mL per 10 g of body weight, and the time was immediately counted after the ink was injected. 2 min and 10 min after the injection of ink, 20 μL of blood was collected from the inner canthus venous plexus respectively, and added to 2 mL of 0.1% Na 2 CO 3 solution, and the optical density (OD) was measured at 600 nm wavelength with a 721 spectrophotometer to obtain Na 2 CO 3 solution was used as blank control. After the second blood collection, the mice were sacrificed immediately, and the liver and spleen were taken out, and the blood stains on the surface of the organs were blotted with filter paper, and weighed. Calculate the phagocytosis index.

NK细胞活性测定(LDH测定法)NK cell activity assay (LDH assay)

各组灌胃给样品,每天1次,连续30d。在试验第30天,每鼠无菌取脾,置于盛有适量无菌Hank's液的小平皿中,用镊子轻轻撕碎,制成单细胞悬液,200目筛网过滤,洗涤,计数,最后用RPMI1640完全培养液调整细胞浓度为2×107个·mL-1。试验前24h将YAC-1细胞(靶细胞)传代培养,应用前用Hank's液洗3次,用RPMI1640完全培养液调整细胞浓度为4×105个·mL-1。取靶细胞和脾细胞悬液(效应细胞)各100μL(效靶比50∶1),加入U型96孔培养板中,靶细胞自然释放孔加靶细胞和培养液各100μL,靶细胞最大释放孔加靶细胞和1%NP40各100μL;上述各项均设3个复孔,于37℃、5%CO2,培养箱中培养4h,离心,每孔吸取上清100μL置平底96孔培养板中,同时加入LDH基质液100μL,反应5min,每孔加入1mol·L-1的HCl 30μL在490nm波长处测光密度(OD)值,计算NK细胞活性。The samples were given to each group by gavage, once a day, for 30 consecutive days. On the 30th day of the experiment, aseptically remove the spleen from each mouse, put it in a small plate filled with an appropriate amount of sterile Hank's solution, and gently tear it up with tweezers to make a single-cell suspension, filter through a 200-mesh sieve, wash, and count , and finally adjust the cell concentration to 2×10 7 ·mL -1 with RPMI1640 complete culture medium. The YAC-1 cells (target cells) were subcultured 24 hours before the test, washed three times with Hank's solution before application, and the cell concentration was adjusted to 4×10 5 ·mL -1 with RPMI1640 complete culture medium. Take 100 μL each of target cells and splenocyte suspension (effector cells) (effect-to-target ratio 50:1), add them into U-shaped 96-well culture plate, add 100 μL each of target cells and culture medium in the natural release holes of target cells, and maximize the release of target cells. Add 100 μL of target cells and 1% NP40 to each well; set up 3 duplicate wells for each of the above items, incubate in an incubator at 37°C and 5% CO 2 for 4 hours, centrifuge, absorb 100 μL of supernatant from each well and place on a flat-bottomed 96-well culture plate At the same time, 100 μL of LDH matrix solution was added, reacted for 5 min, and 30 μL of 1 mol·L -1 HCl was added to each well to measure the optical density (OD) value at a wavelength of 490 nm to calculate the activity of NK cells.

表7不同样品对小鼠NK细胞活性的影响n=10)The influence of table 7 different samples on mouse NK cell activity n=10)

由表7数据可知,与阴性对照组比较,样品1-7组均能提高NK细胞活性,有显著性差异 (p<0.05),其中组合物(样品1-3)有极显著性差异(p<0.01),活性优于单一子实体。As can be seen from the data in Table 7, compared with the negative control group, the sample 1-7 groups can all improve NK cell activity, and there is a significant difference (p<0.05), wherein the composition (sample 1-3) has a very significant difference (p <0.01), the activity is better than single fruiting body.

综合表4-7实验结果可知,在提高ConA诱导的小鼠脾淋巴细胞的增殖能力和增强NK细胞活性方面,组合物(样品1-3)优于单一子实体(蛹草拟青霉蛹基虫草,古尼拟青霉菌蛹基虫草,细脚拟青霉菌蛹基虫草,玫烟色拟青霉菌蛹基虫草)。The comprehensive table 4-7 experimental result shows that, in improving the proliferative ability of the mouse spleen lymphocyte induced by ConA and enhancing NK cell activity, composition (sample 1-3) is better than single fruiting body (Paecilomyces pumilaris pumilaris cordyceps , Paecilomyces gourney, Paecilomyces pupae, Cordyceps pupaecilium, Paecilomyces pupae, Cordyceps pupaeum, Paecilomyces pupaeum, Cordyceps pupae).

实施例5免疫抑制活性蛹拟青霉组合物胶囊制备Example 5 Preparation of immunosuppressive activity Paecilomyces pulitaris composition capsule

将粉碎后的古尼拟青霉菌蛹基虫草58份,细脚拟青霉菌蛹基虫草40份和玫烟色拟青霉菌蛹基虫草2份(20目)按重量百分比称重后,均匀混合后得到中药组合物,按照常规方法制备成胶囊。After weighing 58 parts of Paecilomyces grunnii Cordyceps pupae, 40 parts of Paecilomyces tenipedes and 2 parts of Paecilomyces pupae (20 mesh) by weight percentage, mix them evenly After obtaining the traditional Chinese medicine composition, it is prepared into capsules according to conventional methods.

实施例6免疫抑制活性蛹拟青霉组合物粉剂制备Example 6 Preparation of Immunosuppressive Active Paecilomyces pupaecilium Composition Powder

将粉碎后的古尼拟青霉菌蛹基虫草70份,细脚拟青霉菌蛹基虫草20份和玫烟色拟青霉菌蛹基虫草10份(20目)按重量百分比称重后,均匀混合后得到中药组合物,按照常规方法制备成粉剂。After 70 parts of pulverized Paecilomyces pumilaris, 20 parts of Paecilomyces pumilaris and 10 parts of Paecilomyces pumilaris (20 mesh) were weighed by weight percentage, they were uniformly mixed Afterwards, the traditional Chinese medicine composition is obtained, which is prepared into powder according to a conventional method.

实施例7免疫抑制活性蛹拟青霉组合物片剂制备Example 7 Preparation of Immunosuppressive Activity Paecilomyces pulitaris Composition Tablet

将粉碎后的古尼拟青霉菌蛹基虫草70份,细脚拟青霉菌蛹基虫草20份和玫烟色拟青霉菌蛹基虫草10份(80目)按重量百分比称重后,均匀混合后得到中药组合物,按照常规方法制备成片剂。70 parts of pulverized Paecilomyces pumilaris, 20 parts of Paecilomyces tenipedes and 10 parts of Paecilomyces pupae (80 mesh) were weighed by weight percentage, and mixed evenly Obtain the Chinese medicine composition afterward, be prepared into tablet according to conventional method.

实施例8免疫抑制活性蛹拟青霉组合物口服液制备Embodiment 8 Preparation of oral liquid of Paecilomyces pulitaris composition with immunosuppressive activity

将粉碎后的古尼拟青霉菌蛹基虫草50份,细脚拟青霉菌蛹基虫草40份和玫烟色拟青霉菌蛹基虫草10份(80目)按重量百分比称重后,均匀混合后得到中药组合物,按照常规方法制备成口服液。After 50 parts of pulverized Paecilomyces pumilaris Cordyceps pulveris, 40 parts of Paecilomyces pumilaris and 10 parts of Paecilomyces pumilaris (80 mesh) were weighed by weight percentage, evenly mixed After obtaining the traditional Chinese medicine composition, it is prepared into an oral liquid according to a conventional method.

实施例9免疫抑制活性蛹拟青霉组合物粉剂抗衰老活性确立Example 9 Immunosuppressive Activity Paecilomyces pupaecillum Composition Powder Anti-aging Activity Establishment

将实施例6中制备的粉剂进行抗衰老活性The powder prepared in embodiment 6 is carried out anti-aging activity

实验动物及分组:雄性Wistar大鼠40只,体重180~220g。按随机数字表法分为正常组、模型组、热量限制组、蛹拟青霉组合物粉剂样品组(实施例6中制备的粉剂)四个组,每组10只。造模及给药:Wistar大鼠适应环境1w后,开始造模。模型组、热量限制组、粉剂样品组以 1%D-半乳糖生理盐水溶液,腹腔注射,1次/d,1ml/100g体重/次,连续6w造成衰老模型,造模同时粉剂样品组给予蛹拟青霉组合物粉剂样品8g/kg/d(相当于生药材量)进行灌胃,正常组、模型组、热量限制组同时以等量的生理盐水灌胃。造模期间每4天称量并记录一次大鼠体重,并根据新的体重进行给药剂量的换算。造模给药期间注意观察并记录各组大鼠的一般状态。Experimental animals and grouping: 40 male Wistar rats, weighing 180-220g. Divided into normal group, model group, caloric restriction group, Paecilomyces pupaecillum composition powder sample group (the powder prepared in embodiment 6) four groups by random number table method, each group 10. Modeling and drug administration: Wistar rats started modeling after 1 week of adaptation to the environment. The model group, the caloric restriction group, and the powder sample group were injected with 1% D-galactose saline solution intraperitoneally, 1 time/d, 1ml/100g body weight/time, for 6 weeks to create an aging model, and the powder sample group was given pupa Paecilomyces composition powder sample 8g/kg/d (equivalent to the amount of raw medicinal materials) was gavaged, and the normal group, the model group, and the caloric restriction group were gavaged with the same amount of normal saline at the same time. During the modeling period, the body weight of the rats was weighed and recorded every 4 days, and the dosage was converted according to the new body weight. Observe and record the general state of the rats in each group during the administration of the model.

动物组织的获取与保存:末次给药后禁食12h。取材时,采用20%的乌拉坦溶液麻醉实验大鼠,将麻醉后的实验大鼠固定在固定板上,腹主动脉取血,然后进行解剖,用镊子小心取出大鼠的肝脏、脑组织,用生理盐水洗净表面的血液,将脑组织分切为左右两半,肝组织亦切取部分,将一半脑组织和部分肝组织放于10%甲醛溶液中固定,别一半脑组织和部分肝组织置-80 ℃冰箱保存,备用。大鼠血液以3500r/min4℃离心10min,取上清,血清分装后于-80℃冰箱保存。Acquisition and preservation of animal tissues: Fasting for 12 hours after the last administration. When collecting materials, use 20% urethane solution to anesthetize the experimental rats, fix the anesthetized experimental rats on a fixed board, take blood from the abdominal aorta, and then dissect it, carefully remove the liver and brain tissue of the rats with tweezers, Wash the blood on the surface with normal saline, cut the brain tissue into left and right halves, and cut out part of the liver tissue, put half of the brain tissue and part of the liver tissue in 10% formaldehyde solution for fixation, and separate the half of the brain tissue and part of the liver tissue Store in -80°C refrigerator for later use. Rat blood was centrifuged at 3500r/min at 4°C for 10min, the supernatant was taken, and the serum was aliquoted and stored in a -80°C refrigerator.

ELISA法检测蛹拟青霉组合物粉剂对衰老大鼠肝组织及脑组织中脂质过氧化物含量的影响:称取大鼠肝组织及脑组织适量,加生理盐水用手动匀浆器制成10%组织匀浆,以3500r/min 4 ℃离心10min,取上清液,分装,并置-80℃冰箱备用。实验时取肝组织匀浆、脑组织匀浆分别测定其中的SOD、T-AOC、MDA的含量,检测方法严格按试剂盒说明书操作。ELISA method to detect the effect of Paecilomyces pupaecomb composition powder on the content of lipid peroxide in the liver tissue and brain tissue of aging rats: Weigh an appropriate amount of rat liver tissue and brain tissue, add physiological saline and use a manual homogenizer to make it 10% tissue homogenate was centrifuged at 3500r/min at 4°C for 10min, the supernatant was taken, aliquoted, and placed in a -80°C refrigerator for later use. During the experiment, liver tissue homogenate and brain tissue homogenate were taken to measure the contents of SOD, T-AOC and MDA respectively, and the detection method was strictly operated according to the instructions of the kit.

表8大鼠肝组织中SOD、MDA和T-AOC含量(n=10)SOD, MDA and T-AOC content ( n=10)

由表8可知,与正常组比较,D-半乳糖诱导的衰老模型组大鼠肝脏组织中SOD活力显著下降(P<0.05),T-AOC活力也显著降低(P<0.05),MDA含量显著增加(P<0.05);热量限制组肝组织中SOD和T-AOC活力较模型组也明显下降,MDA含量较之则明显增加。将蛹拟青霉组合物粉剂组与模型组相比,蛹拟青霉组合物粉剂组大鼠肝脏中的SOD活性和T-AOC 活性显著增加(P<0.05),MDA含量显著减少(P<0.05),变化要优于热量限制组。It can be seen from Table 8 that compared with the normal group, the SOD activity in the liver tissue of rats in the D-galactose-induced aging model group decreased significantly (P<0.05), the T-AOC activity also decreased significantly (P<0.05), and the MDA content significantly decreased. increased (P<0.05); the activities of SOD and T-AOC in the liver tissue of the caloric restriction group were also significantly lower than those of the model group, while the content of MDA was significantly higher than that of the model group. The Paecilomyces pupaecillum composition powder group is compared with the model group, the SOD activity and the T-AOC activity in the rat liver of the Paecilomyces pupaecomposition powder group are significantly increased (P<0.05), and the MDA content is significantly reduced (P<0.05). 0.05), the change was better than that of the caloric restriction group.

表9大鼠脑组织中SOD、MDA和T-AOC含量(n=10)SOD, MDA and T-AOC content ( n=10)

由表9可知,与正常对照组比较,D-半乳糖诱导的衰老模型组大鼠脑组织中SOD活力显著下降(P<0.01),T-AOC活力也显著降低(P<0.01),MDA含量显著增加(P<0.01);与模型组比较,热量限制组和蛹拟青霉组合物粉剂组SOD活性显著增加,T-AOC活力也显著增加,MDA含量显著减少(P<0.05),变化要优于热量限制组。It can be seen from Table 9 that compared with the normal control group, the SOD activity in the brain tissue of rats in the D-galactose-induced aging model group decreased significantly (P<0.01), the T-AOC activity also decreased significantly (P<0.01), and the MDA content Significantly increased (P<0.01); Compared with the model group, the caloric restriction group and the Paecilomyces pupaecillum composition powder group had a significantly increased SOD activity, a significantly increased T-AOC activity, and a significantly reduced MDA content (P<0.05). better than the caloric restriction group.

ELISA法检测蛹拟青霉组合物粉剂对衰老大鼠脑组织中端粒酶活性的影响:称取大鼠脑组织适量,加生理盐水用手动匀浆器制成10%组织匀浆,后以3500r/min离心10min,取上清液,分装,并置-80℃冰箱备用。实验时取大鼠脑组织匀浆液测定脑端粒酶(TE)活性,检测方法严格按试剂盒说明书操作。ELISA method was used to detect the effect of Paecilomyces pupaecomb composition powder on telomerase activity in the brain tissue of aged rats: Weighed an appropriate amount of rat brain tissue, added physiological saline and made 10% tissue homogenate with a manual homogenizer, and then used Centrifuge at 3500r/min for 10min, take the supernatant, aliquot, and store in -80°C refrigerator for later use. During the experiment, the rat brain tissue homogenate was taken to measure brain telomerase (TE) activity, and the detection method was strictly operated according to the instructions of the kit.

表10大鼠脑组织中TE含量(n=10)TE content in the rat brain tissue of table 10 ( n=10)

如表10所示,与模型组比较,正常对照组端粒酶活性明显增加(P<0.01);热量限制组的TE 活性也显著增加;蛹拟青霉组合物粉剂组端粒酶活性较模型组显著增加(P<0.01)。As shown in Table 10, compared with the model group, the telomerase activity of the normal control group was significantly increased (P<0.01); the TE activity of the caloric restriction group was also significantly increased; group significantly increased (P<0.01).

Claims (6)

1. a kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging, by paecilomyces gunniliang bacterium pupa base cordyceps sinensis, carefully Pin paecilomycerol pupa base cordyceps sinensis and Paecilomyces Fumosoroseus pupa base cordyceps sinensis composition.
2. the paecilomycerol pupa base cordyceps sinensis composition of the strengthen immunity anti-aging described in claim 1, it is characterised in that its group Turn into:20~70 parts of paecilomyces gunniliang bacterium pupa base cordyceps sinensis, 20~40 parts of thin pin paecilomycerol pupa base cordyceps sinensis and paecilomyces fumosoroseus 1~10 part of composition of bacterium pupa base cordyceps sinensis, preferably by 50~70 parts of paecilomyces gunniliang bacterium pupa base cordyceps sinensis, thin pin paecilomycerol pupa base worm 2~5 parts of compositions of 30~40 parts of grass and Paecilomyces Fumosoroseus pupa base cordyceps sinensis.
3. the application in immunity antiaging agent, the function is strengthen immunity, anti-aging, alleviates physical fatigue, auxiliary Improve memory etc..
4. a kind of preparation method of the paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging, comprises the following steps:A. By each component crushed after being dried, mesh number is no less than 20 mesh;B. after the powder raw material after crushing is weighed by weight percentage uniformly Obtain Chinese medicine composition of the present invention;The percentage by weight of wherein described raw material forms:Paecilomyces gunniliang bacterium pupa base cordyceps sinensis 20 ~70 parts, thin 20~40 parts of pin paecilomycerol pupa base cordyceps sinensis forms for 1~10 part with Paecilomyces Fumosoroseus pupa base cordyceps sinensis, is preferably By 50~70 parts of paecilomyces gunniliang bacterium pupa base cordyceps sinensis, 30~40 parts of thin pin paecilomycerol pupa base cordyceps sinensis and Paecilomyces Fumosoroseus pupa 2~5 parts of compositions of base cordyceps sinensis;C. pulvis, tablet, capsule or oral liquid is further made in composition.
5. the preparation method of the paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging according to claim 4, It is characterized in that the paecilomyces gunniliang bacterium pupa base cordyceps sinensis, thin pin paecilomycerol pupa base cordyceps sinensis, Paecilomyces Fumosoroseus pupa base worm Feed powder broken mesh number in grassland is 20~80 mesh.
6. the preparation method of the paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging according to claim 4, Characterized in that, formulation method is the common process of the formulation.
CN201711107353.1A 2017-11-10 2017-11-10 A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application Pending CN107661359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711107353.1A CN107661359A (en) 2017-11-10 2017-11-10 A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711107353.1A CN107661359A (en) 2017-11-10 2017-11-10 A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application

Publications (1)

Publication Number Publication Date
CN107661359A true CN107661359A (en) 2018-02-06

Family

ID=61145154

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711107353.1A Pending CN107661359A (en) 2017-11-10 2017-11-10 A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application

Country Status (1)

Country Link
CN (1) CN107661359A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113072458A (en) * 2021-04-12 2021-07-06 安徽农业大学 Fumonisin A with anti-aging activity and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113072458A (en) * 2021-04-12 2021-07-06 安徽农业大学 Fumonisin A with anti-aging activity and preparation method thereof

Similar Documents

Publication Publication Date Title
KR100922311B1 (en) Double Culture Method of Chaga, Situation Mushroom, Ganoderma Lucidum Mushroom, Blossom Mushroom and Cordyceps Sinensis Producing Substances Containing Activated Sugar-related Compounds
CN103800390B (en) Health-care product with immunity-reinforcing and liver-protecting functions, preparation method and application thereof
CN101418325B (en) Inonotus obliquus extracellular and intracellular mixed polysaccharide, and preparation method and pharmaceutical application thereof
CN110693921B (en) A kind of extract of artificially cultivated Phellinus linteus fruiting body and its preparation method and application
CN103735825B (en) Comprehensively regulating Chinese medicine composition and application thereof
CN101805763B (en) Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity
Baral et al. A review of Chinese Cordyceps with special reference to Nepal, focusing on conservation
CN103477871B (en) Cultivation method and application of cordyceps militaris
CN104940479A (en) TCM composition for treating AD diseases
KR100918628B1 (en) Liver toxicity prevention or treatment composition containing Ssanghwatang fungi fermentation as an active ingredient
CN105664140A (en) Glycopeptide composition as well as preparation method and application thereof
CN103285043B (en) There is the preparation method of the edible fungal protein matter extract of antitumor efficacy
KR20220020147A (en) Method for preparing Phellinus linteus mycelia extract or Phellinus linteus mycelia extract powder and composition for enhancing immunity comprising them as an active ingredient
WO2016082327A1 (en) Processing method of cordyceps sinensis mycelium
KR100814351B1 (en) Physiologically Active Compositions of Basidiomycetes and Araliaaceae
CN107661359A (en) A kind of paecilomycerol pupa base cordyceps sinensis composition of strengthen immunity anti-aging and its application
CN109248177B (en) Preparation of crocodile amour effective component and application of crocodile amour effective component in oxidation resistance and hepatic fibrosis resistance
Wei et al. Anti-fatigue activity of extract form the submerged fermentation of Ganoderma Lucidum using Radix astragali as substrate
CN101112396A (en) Extract of sparassis crispa MH-3 bacterial strain and method for preparing the same and use thereof
CN102266519A (en) Chinese medicinal composition for treating tuberculosis and preparation method thereof
CN114504601A (en) Application of ganoderma lucidum in preparation of anti-novel coronavirus product
CN103272216B (en) Pleurotus citrinopileatus protein extract and antineoplastic application thereof
CN104906145A (en) Medical application of paecilomyces hepiali mutant strain PH40 in treating diabetes
CN106511401A (en) Preparation method and application of cordyceps taii mycelia polysaccharides
CN102585024A (en) Isaria feline crude polysaccharide, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180206